UnknownPhase 4

Sensitivity and Specificity of QuantiFeron -TB Gold Test (QFT-G)in Patients With Psoriasis

Israel150 participantsStarted 2010-11

Plain-language summary

The purpose of this study is to determine the level of agreement between QuantiFeron -TB Gold test (QFT-G)and Tubeculin skin test (TST)for screening of latent tuberculosis in patients suffering from psoriasis.

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with psoriasis and psoriatic arthritis * Aged 18-90 Exclusion Criteria: * History of TB * Known allergy to TST * Current or past treatment with anti-TNF alpha

What they're measuring

The level of agreement between TST and QTF in patients with psoriasis in comparison with controls

Timeframe: 3 days

Trial details

NCT IDNCT01223976

SponsorTel-Aviv Sourasky Medical Center

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2011-06

Contact for this trial

Ori Elkayam, MD

97236973668 orie@tasmc.health.gov.il

View on ClinicalTrials.gov More Tuberculosis trials